Impax Laboratories (IPXL)

18.43 +0.01  +0.05%  May 20, 8:00PM
Add to Watchlists Create an Alert

Impax Laboratories Revenue Quarterly YoY Growth:

15.49% for March 31, 2013
View Full Chart

Impax Laboratories Revenue Quarterly YoY Growth Chart

    Impax Laboratories Historical Revenue Quarterly YoY Growth Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 15.49%
    Dec. 31, 2012 -11.03%
    Sept. 30, 2012 21.48%
    June 30, 2012 32.26%
    March 31, 2012 18.33%
    Dec. 31, 2011 60.00%
    Sept. 30, 2011 -60.57%
    June 30, 2011 -17.78%
    March 31, 2011 -66.40%
    Dec. 31, 2010 -43.73%
    Sept. 30, 2010 368.1%
    June 30, 2010 162.1%
    March 31, 2010 448.8%
    Dec. 31, 2009 294.1%
    Sept. 30, 2009 76.61%
    June 30, 2009 -25.75%
    March 31, 2009 17.99%
    Dec. 31, 2008
       
    Sept. 30, 2008
    June 30, 2008
    March 31, 2008 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro

    About Revenue Growth

    Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.

    If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
    Learn More

    Get data for

    IPXL Revenue Quarterly YoY Growth Benchmarks

    Companies
    Endo Health Solutions 2.59%
    Actavis 24.35%
    Teva Pharmaceutical Industries -3.94%

    IPXL Revenue Quarterly YoY Growth Rankings

    Overall 84th percentile
    1256 of 8002
    Sector 73rd percentile
    175 of 650 in Healthcare
    Industry 64th percentile
    23 of 65 in Drug Manufacturers - Specialty & Generic

    IPXL Revenue Quarterly YoY Growth Range, Past 5 Years

    Minimum -66.40% Mar 2011
    Maximum 448.8% Mar 2010
    Average 75.88%